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A multidrug resistant isolate, identified as Citrobacter amalonaticus using MALDI-TOF MS and 
confirmed by genomic analysis, was recovered from a pediatric patient in a hospital from 
Buenos Aires, Argentina. By whole-genome sequencing a total of 16 resistance genes were 
detected, including blaNDM-1 and mcr-1.5. To the best of our knowledge this is the first 
description of these two genes together in a clinical isolate of the Citrobacter genus. 
 
INTRODUCTION 
Citrobacter is a gram-negative coliform bacterial genus comprising 14 species that have been 
isolated from water, soil, food and the gastrointestinal tract of humans and animals (Clermont 
et al., 2015). C. freundii and C. koseri are the most common species recovered from human 
infections while C. amalonaticus is seldom isolated from faecal and urine samples and only 
occasionally associated with invasive infections, like osteomyelitis, arthritis and peritonitis 
(Garcia et al., 2016; Maraki et al., 2017; Wong et al., 2012). Citrobacter spp. are usually 
susceptible to third-generation cephalosporins, carbapenem and colistin (Maraki et al., 2017). 
However, carbapenem resistant Citrobacter spp. isolates have been reported due to the 
acquisition of worldwide disseminated carbapenemases, such as New Delhi Metallo-β-
lactamase (NDM) (Arana et al., 2017; Hammerum et al., 2016; Pasteran et al., 2016). In the last 
few years, a transferable colistin-resistant mechanism mediated by mcr genes has been 
recently described (8). mcr-1 gene has been found in several Enterobacteriaceae genus and 
species but it has mainly been detected in Escherichia coli from animal, food, environmental 
and human sources (Al-Tawfiq et al., 2017; Rapoport et al., 2016; Saavedra et al., 2017). Here, 
we report the characterization of a clinical multidrug resistant (MDR) C. amalonaticus isolate 
carrying blaNDM-1 and mcr-1.5 genes.  
 

















On February 2016, isolate M21015 was recovered in a pediatric hospital in Buenos Aires from 
an oncologic four-year old patient, during an active carbapenemase surveillance program for 
asymptomatic rectal colonization, and confirmed as C. amalonaticus by Vitek2, VitekMS 
(bioMérieux) and MALDI-TOF MS Biotyper 3.0 (Bruker Daltonics). The isolate was sent to the 
Argentinian National Reference Laboratory for Antimicrobial Resistance for further 
characterization.  
Antimicrobial susceptibility was evaluated by Sensititre ARGNF customized plates (Trek 
Diagnostic Systems, Thermo Fisher Scientific), and interpreted according to the Clinical and 
Laboratory Standards Institute or the European Committee on Antimicrobial Susceptibility 
Testing (colistin and tigecycline) criteria (Clinical and Laboratory Standards Institute (CLSI)., 
2017; “The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for 
interpretation of MICs and zone diameters. Version 7.0, 2017. http://www.eucast.org.,” n.d.). 
The imipenem-EDTA double-disk synergy test was used to detect metallo-ß-lactamase (MBL) 
activity. The presence of MBL (blaNDM, blaIMP and blaVIM) and mcr-1 genes were detected by in 
house PCR. 
C. amalonaticus M21015 was analysed by whole genome sequencing (WGS) using Nextera XT 
for library preparation and Illumina compact MiSeq system for sequencing. Plasmids 
containing mcr and blaNDM genes were independently transferred by biparental conjugation to 
E. coli J53, and the transconjugants selected with colistin (2 µg/ml) or meropenem (0.2 µg/ml), 
respectively, and sodium azide (100 µg/ml)(Gomez et al., 2011). Plasmids were extracted and 
purified for Illumina sequencing, and analyzed as previously described (Tijet et al., 2016). 
Antimicrobial resistance genes were predicted using the ResFinder, version 3.0 (Zankari et al., 
2012).  
 

















C. amalonaticus M21015 was resistant (μg/mL) to imipenem (≥16), meropenem (≥32), 
cefotaxime (≥64), ceftazidime (≥64), cefepime (≥32), amikacin (≥64), gentamicin (≥16), 
trimethoprim-sulfamethoxazole (≥4) and colistin (≥8), and susceptible to aztreonam (≤8), 
ciprofloxacin (≤0.06), fosfomycin (≤32), minocycline (≤4) and tigecycline (≤0.5). MBL inhibition 
was associated with the presence of blaNDM gene. Resistance to colistin was associated with 
the presence of mcr-1-like gene.  
Two plasmids were transferred individually from C. amalonaticus M21015 to E. coli J53 by 
conjugation, and subsequently sequenced. One of them, named here pMCR-M21015, 
harboured the mcr-1.5 variant(Tijet et al., 2017). pMCR-M21015 (62,891 bp) belonged to the 
incompatibility group IncI2 sharing >99.9% identity with pMCR-M15049 plasmid (accession 
number KY471308) of E. coli M15049 also isolated in Argentina(Tijet et al., 2017). mcr-1.5 and 
pap2 genes were identified in a 2,749 bp contig. The presence of two copies of ISApI1 in the 
same orientation flanking them was verified by PCR and Sanger sequencing, as well as the 2-bp 
putative target site duplications, confirming the presence of the composite transposon 
Tn6330(Liu et al., 2016). No other antimicrobial resistance gene was identified in this plasmid 
(Suppl. Figure 1). The finding of mcr-1 in Citrobacter spp. is infrequent and to the best of our 
knowledge has not been described in C. amalonaticus.  
Sequencing of the second plasmid (named pNDM-M21015) showed that blaNDM-1 is located in a 
type 1 IncC2 plasmid of 138,998 bp with 99% identity with pKP1-NDM-1 (KF992018). blaNDM-1 
was located within a truncated Tn125 structure previously reported paper de Wailan  et 
al.(Wailan et al., 2015). pNDM-M21015 also contains blaCMY-6, rmtC, sul1, and some small MDR 
genes encoding for the ethidium bromide-methyl viologen resistance protein EmrE and the 
quaternary ammonium compound-resistance protein SugE, as well as the bleomycin resistance 
protein (bleMBL) associated to blaNDM (Suppl. Figure 2). 
In addition, other mechanisms of resistance were identified by WGS analysis (Table 1): to 

















chromosomally encoded class A β-lactamase similar to Sed-1 from Citrobacter sedlakii)(Petrella 
et al., 2001). An efflux pump similar to OqxA/B (~90% nucleotide identity with OqxA/B found 
on K. pneumoniae chromosomes) was also identified, but the MIC for ciprofloxacin suggests 
that it is not active against fluoroquinolones.  
The identification to the species level of Citrobacter is controversial (Ribeiro et al., 2015). The 
conventional biochemical characterization and MALDI-TOF MS methods yield reliable results 
with approx. 90% and 95% accuracy for each methodology, respectively (Kolínská et al., 2015). 
The use of 16S rRNA gene sequences displays limited resolution distinguishing only three 
groups within the genus, where C. amalonaticus is included in group II together with C. 
farmeri, C. sedlakii and C. rodentium (Clermont et al., 2015). A previously described multilocus 
sequence analysis of a 2,082 bp concatenated sequence of fusA, pyrG, leuS and rpoB genes 
was used to confirm the isolate identity at the species level (Clermont et al., 2015). A 
phylogenetic analysis was performed including the sequences of 28 isolates representing 14 
well defined Citrobacter species (Figure 1). C. amalonaticus M21015 grouped together with C. 
amalonaticus FDAARGOS165 and CIP 82.89 in group II (Figure 1), confirming the identification 
obtained by biochemical and proteomic methods. 
C. amalonaticus is an opportunistic pathogen rarely associated with MDR phenotypes (Garcia 
et al., 2016; Maraki et al., 2017; Wong et al., 2012). To the best of our knowledge this is the 
first description of both blaNDM and mcr-1-like genes in the Citrobacter genus, co-existing with 
other 14 determinants of antimicrobial resistance in this clinical isolate of C. amalonaticus. This 
emergence is coincident with other reports suggesting an increase in the isolation of MDR 
Citrobacter spp. (Arana et al., 2017; Hammerum et al., 2016; Pasteran et al., 2016). Further 
studies are required to determine its public health significance and the degree of 
dissemination since Citrobacter is not frequently included in surveillance programs for MDR 
organisms. Remarkably, a highly similar IncI2 pMCR plasmid was now described in two genera 

















2017) but to other Enterobacteriaceae. Furthermore, the presence of mcr-1.5 in an active 
composite transposon creates the potential for its dissemination to other plasmids, increasing 
the risk of a more effective spread of polymyxin resistance. 
The following are the supplementary data related to this article. 
Supplementary Table 1. Primers used to detect blaNDM, blaIMP, blaVIM and mcr-1 genes. 
Suppl. Table 2. Antimicrobial susceptibility of C. amalonaticus M21015 (donor), E. coli J53 
(acceptor), and two E. coli transconjugants. 
Supplementary figures 
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Figure 1. Phylogenetic analysis by maximum likelihood method of Citrobacter species. 
FOOTNOTE. The evolutionary history was inferred by using the Maximum Likelihood method 
based on the Jukes-Cantor model. Branch lengths measured in the number of substitutions per 
site. The analysis included 29 nucleotide sequences representing 14 Citrobacter species. 
Groups I, II and III were described in the text. Phylogenetic analyses were conducted in MEGA6 


















Table 1. Summary of resistance genes detected by plasmid and whole-genome sequencing 
 
Antibiotic affected Resistance gene Identity (%) GenBank Accession no. 
Polymyxins  mcr-1.5 100 KP347127 
ß-Lactams  blaNDM-1 100 FN396876 
blaCMY-6 100 AJ011293 
blaTEM-1B 100 JF910132 
blaSED-1 82.64 AF321608 
Aminoglycosides rmtC 100 AB194779 
aadA1 100 JQ414041 
aadA2 100 JQ364967 
aacA4 100 KM278199 
aph(3')-Ia 100 V00359 
Phenicols floR 98.11 AF118107 
cmlA1 99.92 M64556 
Sulphonamide sul1 100 CP002151 
sul2 100 GQ421466 
sul3 100 AJ459418 
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